Replies to post #1953 on Skye Bioscience Inc (SKYE)

[frozenspokes]

Now it's all about pipeline execution and uplisting. There is a lot more required to get to a major board than just wanting to be there and this size of a raise allows them to execute short term and move up when the time is right. When they start executing on their catalysts over the next 6 months, the stock price will rise and the uplist will be at a lower reverse split if any at all. Hopefully none is required. Big money still won't touch the pinkies, so getting to a big board is a goal, but need to execute now that they have funding first. Agree that NMUS has a game plan and it's mapped out. It's strategic and how a good early stage biotech becomes successful

[The Rooster]

Vinpat - I'd have to agree, the guys affiliated with NMUS aren't foolish, in fact - they're quite brilliant. I'm confident as well that they have mapped out a strategic plan of attack for the company, which is why the funding was such a substantial amount.

Exciting times ahead for NMUS.


$NMUS

[Eleveninches]

VINPAT is spot on!